Co-inhibition of EZH2 and the PI3K/AKT/mTORC1 pathway produced superior antitumor activity in both murine and human preclinical models of plastic PCa, especially in castration settings where AR signaling is suppressed. Here, AKT1 is linked to posterior cortical atrophy.